Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXHL2000335	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Import Drug Application	2020-12-21	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	In Review	2020-12-19	view
JXHL2000339	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Import Drug Application	2020-12-21	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	In Review	2020-12-19	view
JXHL2000338	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Import Drug Application	2020-12-21	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	In Review	2020-12-19	view
JXHL2000337	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Import Drug Application	2020-12-21	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	In Review	2020-12-19	view
JXHL2000336	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Import Drug Application	2020-12-21	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	In Review	2020-12-19	view
JXHL2000360	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Import Drug Application	2021-01-05	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	In Review	2021-01-04	view
JXHL2000359	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Import Drug Application	2021-01-05	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	In Review	2021-01-04	view
JXHL2000358	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Import Drug Application	2021-01-05	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	In Review	2021-01-04	view
JXHL2000357	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Import Drug Application	2021-01-05	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	In Review	2021-01-04	view
JXHL2000356	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Import Drug Application	2021-01-05	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd	In Review	2021-01-04	view
JXHL2101061	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Import Drug Application	2021-05-27					view
JXHL2101060	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Import Drug Application	2021-05-27					view
JXHL2101063	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Import Drug Application	2021-05-27					view
JXHL2101062	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Import Drug Application	2021-05-27					view
JXHL2101064	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Import Drug Application	2021-05-27					view
JXHB2200138	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Supplementary Application	2022-09-18					view
JXHB2200139	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Supplementary Application	2022-09-18					view
JXHB2200142	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Supplementary Application	2022-09-18					view
JXHB2200140	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Supplementary Application	2022-09-18					view
JXHB2200141	BI 456906 注射液	survodutide	Injection	Chemical Drugs(1)	Supplementary Application	2022-09-18					view